| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 620,313 | 525,901 | 543,797 | 799,817 | | Cost of Revenue | 683,430 | 418,254 | 430,728 | (2,252,626) | | | Gross Profit | (63,117) | 107,647 | 113,069 | 3,052,443 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (131,756) | 72,592 | 68,411 | 3,014,763 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 68,639 | 35,055 | 44,658 | 37,680 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,095 | 7,725 |
-
| 2,958 | | Earnings Before Interest And Taxes | 75,734 | 42,780 | 44,658 | 40,165 | | Interest Expense | 23,027 | 19,788 | 12,606 | 18,185 | | Income Before Tax | 52,707 | 22,992 | 32,052 | 21,980 | | Income Tax Expense | 18,753 | 7,040 | 11,184 | 8,086 | | Minority Interest | (1,417) | 473 | (473) | (473) | | | | Net Income From Continuing Ops | 32,537 | 16,425 | 20,395 | 13,894 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 32,537 | 16,425 | 20,395 | 13,894 | | Preferred Stock And Other Adjustments | 946 | (946) |
-
|
-
| | | Net Income Applicable To Common Shares | $33,483 | $15,479 | $20,395 | $13,894 |
|
0.31% Nasdaq 0.00%
Income Statement
